Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,039 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Factors Affecting Nonfunctioning Small Pancreatic Neuroendocrine Neoplasms and Proposed New Treatment Strategies.
Hijioka S, Yamashige D, Esaki M, Honda G, Higuchi R, Masui T, Shimizu Y, Ohtsuka M, Kumamoto Y, Katanuma A, Gotohda N, Akita H, Unno M, Endo I, Yokoyama Y, Yamada S, Matsumoto I, Ohtsuka T, Hirano S, Yasuda H, Kawai M, Aoki T, Nakamura M, Hashimoto D, Rikiyama T, Horiguchi A, Fujii T, Mizuno S, Hanada K, Tani M, Hatori T, Ito T, Okuno M, Kagawa S, Tajima H, Ishii T, Sugimoto M, Onoe S, Takami H, Takada R, Miura T, Kurita Y, Kamei K, Mataki Y, Okazaki K, Takeyama Y, Yamaue H, Satoi S; Japan Pancreas Society Clinical Research Promotion Committee Group (Corporate Authorship). Hijioka S, et al. Among authors: akita h. Clin Gastroenterol Hepatol. 2024 Apr 13:S1542-3565(24)00351-3. doi: 10.1016/j.cgh.2024.03.029. Online ahead of print. Clin Gastroenterol Hepatol. 2024. PMID: 38615727 Free article.
SPARC accelerates biliary tract cancer progression through CTGF-mediated tumor-stroma interactions: SPARC as a prognostic marker of survival after neoadjuvant therapy.
Takayama H, Kobayashi S, Gotoh K, Sasaki K, Iwagami Y, Yamada D, Tomimaru Y, Akita H, Asaoka T, Noda T, Wada H, Takahashi H, Tanemura M, Doki Y, Eguchi H. Takayama H, et al. Among authors: akita h. J Cancer Res Clin Oncol. 2023 Sep;149(12):10935-10950. doi: 10.1007/s00432-023-04835-7. Epub 2023 Jun 17. J Cancer Res Clin Oncol. 2023. PMID: 37330435
ASO Author Reflections: A Novel Combination Index of Sialyl-Lewis Antigen-Related Tumor Markers Enhances Predictive Significance in Patients with a Modest Radiological Response to Neoadjuvant Treatment for Pancreatic Cancer.
Miyahara S, Takahashi H, Akita H, Sasaki K, Mukai Y, Iwagami Y, Hasegawa S, Yamada D, Tomimaru Y, Noda T, Wada H, Kobayashi S, Doki Y, Eguchi H. Miyahara S, et al. Among authors: akita h. Ann Surg Oncol. 2024 May;31(5):2971-2972. doi: 10.1245/s10434-024-15021-5. Epub 2024 Feb 16. Ann Surg Oncol. 2024. PMID: 38363472 No abstract available.
Prognostic Significance of Biologic Factors in Patients with a Modest Radiologic Response to Neoadjuvant Treatment for Resectable and Borderline Resectable Pancreatic Cancers: Impact of the Combination Index of Sialyl-Lewis Antigen-Related Tumor Markers.
Miyahara S, Takahashi H, Akita H, Sasaki K, Mukai Y, Iwagami Y, Hasegawa S, Yamada D, Tomimaru Y, Noda T, Wada H, Kobayashi S, Doki Y, Eguchi H. Miyahara S, et al. Among authors: akita h. Ann Surg Oncol. 2024 May;31(5):2932-2942. doi: 10.1245/s10434-024-14945-2. Epub 2024 Feb 17. Ann Surg Oncol. 2024. PMID: 38368291
The impact of cellular senescence and senescence‑associated secretory phenotype in cancer‑associated fibroblasts on the malignancy of pancreatic cancer.
Higashiguchi M, Murakami H, Akita H, Kobayashi S, Takahama S, Iwagami Y, Yamada D, Tomimaru Y, Noda T, Gotoh K, Doki Y, Yamamoto T, Eguchi H. Higashiguchi M, et al. Among authors: akita h. Oncol Rep. 2023 May;49(5):98. doi: 10.3892/or.2023.8535. Epub 2023 Mar 31. Oncol Rep. 2023. PMID: 36999632 Free PMC article.
Significance of Comprehensive Analysis of Preoperative Sarcopenia Based on Muscle Mass, Muscle Strength, and Physical Function for the Prognosis of Patients with Esophageal Cancer.
Kanemura T, Takeoka T, Sugase T, Urakawa S, Masuike Y, Shinno N, Hara H, Kitakaze M, Kubo M, Mukai Y, Sueda T, Hasegawa S, Akita H, Nishimura J, Wada H, Yasui M, Omori T, Miyata H. Kanemura T, et al. Among authors: akita h. Ann Surg Oncol. 2024 Feb;31(2):818-826. doi: 10.1245/s10434-023-14306-5. Epub 2023 Nov 21. Ann Surg Oncol. 2024. PMID: 37989955
Short-term Outcomes of Adjuvant Nivolumab After Neoadjuvant Chemotherapy in Patients With Resected Esophageal Squamous Cell Carcinoma.
Sugase T, Kanemura T, Takeoka T, Matsuura N, Masuike Y, Shinno N, Hara H, Kitakaze M, Kubo M, Mukai Y, Sueda T, Hasegawa S, Akita H, Nishimura J, Wada H, Yasui M, Omori T, Miyata H. Sugase T, et al. Among authors: akita h. Anticancer Res. 2024 Jan;44(1):185-193. doi: 10.21873/anticanres.16801. Anticancer Res. 2024. PMID: 38159967
1,039 results